NSC95397 Is a Novel HIV-1 Latency-Reversing Agent
Open Access
Abstract
The latent viral reservoir represents one of the major barriers to curing HIV-1. Focus on the “kick and kill” (also called “shock and kill”) approach, in which virus expression is reactivated, and then cells producing virus are selectively depleted, has led to the discovery of many latency-reversing agents (LRAs) that have furthered our understanding of the mechanisms driving HIV-1 latency and latency reversal. Thus far, individual compounds have yet to be robust enough to work as a therapy, highlighting the importance of identifying new compounds that target novel pathways and synergize with known LRAs. In this study, we identified a promising LRA, NSC95397, from a screen of ~4250 compounds. We validated that NSC95397 reactivates latent viral transcription and protein expression from cells with unique integration events and across different latency models. Co-treating cells with NSC95397 and known LRAs demonstrated that NSC95397 synergizes with different drugs under both standard normoxic and physiological hypoxic conditions. NSC95397 does not globally increase open chromatin, and bulk RNA sequencing revealed that NSC95397 does not greatly increase cellular transcription. Instead, NSC95397 downregulates pathways key to metabolism, cell growth, and DNA repair—highlighting the potential of these pathways in regulating HIV-1 latency. Overall, we identified NSC95397 as a novel LRA that does not largely alter global transcription, shows potential for synergy with known LRAs, and may act through novel pathways not previously recognized for their ability to modulate HIV-1 latency.Keywords
All Related Versions
Funding Information
- NIH (R01AI147837, U54 AI170660-, AI007323)
- NIH (R01AI147837, U54 AI170660-, AI007323)
- UCLA DGSOM (R01AI147837, U54 AI170660-, AI007323)
- James B. Pendleton Charitable Trust and the McCarthy Family Foundation (R01AI147837, U54 AI170660-, AI007323)
- Ruth L. Kirschstein National Research Service (R01AI147837, U54 AI170660-, AI007323)
This publication has 48 references indexed in Scilit:
- Hypoxic microenvironment shapes HIV-1 replication and latencyCommunications Biology, 2020
- Metascape provides a biologist-oriented resource for the analysis of systems-level datasetsNature Communications, 2019
- The mTOR Complex Controls HIV LatencyCell Host & Microbe, 2016
- The Molecular Signatures Database Hallmark Gene Set CollectionCell Systems, 2015
- Frequently asked questions in drug combinations and the mass-action law-based answersSynergy, 2014
- Novel anti-inflammatory function of NSC95397 by the suppression of multiple kinasesBiochemical Pharmacology, 2014
- High-throughput screen using a single-cell tyrosine phosphatase assay reveals biologically active inhibitors of tyrosine phosphatase CD45Proceedings of the National Academy of Sciences, 2012
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005
- Regulation of NF-κB and HIV-1 LTR Activity in Mouse L Cells by Ultraviolet Radiation: LTRtrans-Activation in a Nonirradiated Genome in HeterokaryonsExperimental Cell Research, 1997
- Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitorsAdvances in Enzyme Regulation, 1984